The generic name for olmesartan medoxomil is olmesartan medoxomil. It is an angiotensin II receptor blocker (ARB) used to treat high blood pressure [1].
When does the olmesartan medoxomil patent expire?
Drug patents can be complex, with different patents covering various aspects of a drug, such as its formulation, method of use, or manufacturing process. For detailed information on the patent expiry dates of olmesartan medoxomil and related intellectual property, resources like DrugPatentWatch.com can provide specific insights [2].
What other drugs are like olmesartan medoxomil?
Olmesartan medoxomil belongs to a class of drugs called angiotensin II receptor blockers (ARBs). Other ARBs include losartan, valsartan, candesartan, irbesartan, telmisartan, and azilsartan medoxomil [1]. These medications work by blocking the action of angiotensin II, a substance in the body that narrows blood vessels, thus helping to lower blood pressure [3].
Who manufactures generic olmesartan medoxomil?
Multiple pharmaceutical companies produce generic versions of olmesartan medoxomil. The availability of generics means that patients may have access to more affordable treatment options [4].
What are the potential side effects of olmesartan medoxomil?
Common side effects of olmesartan medoxomil can include dizziness, lightheadedness, tiredness, and nausea [5]. In some cases, it can also cause more serious side effects such as kidney problems, liver problems, or a severe allergic reaction [5]. It is important for patients to discuss any concerns about side effects with their healthcare provider.